Boehringer Ingelheim USA Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIRT 1696 BS
Drug: Placebo
Other: Grapefruit juice (GFJ)
Other: High fat meal (HFM)

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 46

Registration Number: NCT02254096

Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Salmeterol MDI high
Drug: Salmeterol Diskus low
Drug: Salmeterol Diskus high
Drug: Salmeterol MDI low

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 26

Registration Number: NCT02254226

Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: BEA 2180 BR - rising dose

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 24

Registration Number: NCT02254135

Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: BILR 355 BS, solution
Drug: BILR 355 BS, tablet
Drug: Ritonavir

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 100

Registration Number: NCT02253914

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: EFV
Drug: TPV/RTV - high dose
Drug: TPV/RTV - low dose

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 68

Registration Number: NCT02253823

Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BILR 355 BS
Drug: Ritonavir
Drug: TRUVADA

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 33

Registration Number: NCT02253901

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BEA 2180 BR
Drug: Placebo
Device: Respimat®

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 59

Registration Number: NCT02254122

Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BILR 355 - Treatment D (current tablet formulation)
Drug: BILR 355 - Treatment A (current tablet formulation)
Drug: BILR 355 - Treatment B (new tablet formulation)
Drug: BILR 355 - Treatment E (new capsule formulation)
Drug: BILR 355 - Treatment C (new capsule formulation)
Drug: Ritonavir

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 40

Registration Number: NCT02253940

Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Carbamazepine
Drug: Tipranavir
Drug: Ritonavir

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 28

Registration Number: NCT02253849

Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tipranavir (TPV)
Drug: Ritonavir
Drug: Omeprazole

First Posted Date: 2014-10-01

Last Posted Date: 2014-10-01

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 15

Registration Number: NCT02253875

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy